Home
Hongfu Li
Foodtalks
Kangmaichen Biotechnology
Director of the Technical Research Institute

Hongfu Li, Qingdao Kangmaichen Director of the Technical Research Institute, Qingdao medicine and food cognate traditional Chinese medicine fermentation technology innovation center director, senior engineer, health manager, standing member of Marine Chinese Medicine Branch of Shandong Chinese Medicine Association, member of Chinese Medicine Fermentation Medicine Professional Committee of China Chinese Medicine Association, has been deeply engaged in probiotics and Chinese medicine fermentation research and development for 20 years. Secretary General of Micro-Ecology Branch of Shandong Preventive Medical Association (2011-2020), rated as top-notch talent and model worker of Qingdao West Coast New District, won 1 first prize of Science and Technology Progress of Shandong Province, 1 first prize of technology invention of Qingdao City, and project evaluation expert of Qingdao Science and Technology Bureau; Successfully organized the promotion of more than 40 national first-class biological new drugs, health food and functional food innovation and research; More than 20 invention patents were authorized for new drugs, new strains and traditional Chinese medicine fermentation; To organize and promote research and development of national 863 program projects, provincial key projects and municipal key projects.


Event Introduction
Foodtalks
 · 05/08 (Day 1)
FBIF iFood Show · Foodtalks
11:20
Kangmaichen: How to Achieve Innovative Breakthroughs in the Fermented Traditional Chinese Medicine (TCM) Sector?

Fermented TCM ingredients are emerging as a new hotspot in the food and beverage industry, with a promising market outlook and increasing industry attention.

Qingdao Kangmaichen has been deeply engaged in the field of fermented TCM for over a decade, mastering core technologies, holding proprietary strains, and developing health products to pharmaceutical standards. The company adopts an industry-unique benchmark—measuring success by a twofold enhancement in efficacy post-fermentation—and has completed three randomized, double-blind, placebo-controlled clinical trials involving 240 participants, validating product efficacy and safety. In May 2024, Kangmaichen assisted a major corporation in launching a liver health product, which achieved over 80 million RMB in sales within its first year. The company is now a key supplier of fermented TCM ingredients and products to multiple publicly listed companies.

Leveraging its extensive research experience, Kangmaichen will explore in this session how bio-transformation through fermentation can drive innovation in TCM, unlock new opportunities in this niche sector, and provide high-quality, scientifically backed, and highly effective ingredient and product solutions.

Link to agenda